The cysteine-rich protein progranulin (PGRN) has been implicated in the pathobiology of several diseases including neurodegeneration and lysosomal storage related diseases (Baker, Nature 2006; Cruts, Nature 2006; Neumann, Science 2006; Smith, Am J Hum Genet 2012). Progranulin can be processed into bioactive granulin peptides, the number of which vary from species to species. C. elegans progranulin contains 3 granulins. Despite the variance in number of domains, the granulins share a stable, compact structure of beta-pleated sheets connected by disulfide bonds(Palfree, Plos One 2015). Studies have shown that loss of progranulin leads to features of accelerated aging, such as lipofuscin deposits and decreased lysosome protease activity (Ahmed, The American Journal of Pathology 2010; Ward, Science Translational Medicine 2017). In killifish, progranulin polymorphisms segregate with a short-lived aging phenotype (H151Q, C449W, R158H) (Valenzano, Cell 2015). The cysteine to tryptophan polymorphism is particularly interesting due to the cysteine's structural contribution to disulfide bonds. In addition, the histidine to glutamine polymorphism could potentially alter pH sensitivity. We have shown that
pgrn-1(-) animals demonstrate a robust, stress-resistant phenotype that interestingly, can be decoupled from lifespan extension (Butler, J Neurosci 2019; Meredith, Plos Genetics 2013). Furthermore, progranulin acts in the lysosome and directly increases the activity of cathepsin-D (CTSD), a crucial lysosomal protease (Butler, Human Molecular Genetics 2018). We hypothesize that while complete absence of progranulin and granulin does not affect lifespan, that the polymorphisms in the granulin domains will impact aging and lifespan as well as stress response via regulation of lysosomal protease activity. To address this, we have created single copy insertions using MosSCI of these progranulin SNPs into C. elegans. We plan to test lifespan of these worms. We will also measure markers of aging and test stress response. To better understand potential molecular mechanisms, we will use molecular modeling to elucidate changes to progranulin and CTSD/ASP-3 interactions and test these in vivo. We anticipate that certain progranulin polymorphisms will increase lifespan and healthspan. We also predict that stress resistance will improve. We anticipate these will be a result of progranulin polymorphisms enhancing proteostasis via improved lysosomal protease activity.